SEARCH RESULTS FOR: "Tag: IMMU"
REFINE YOUR SEARCH:
RECENT
Last Month(2)
ARTICLES/BLOGS
2019(5)
2018(4)
2017(2)
2015(1)
CATEGORIES
Buzz Stocks(4)
Intraday Option Activity(2)
Midday Market Check(1)
Opening View(1)
Quantitative Analysis(5)
Stocks On the Move(1)
Technical Analysis(1)

9/30/2019 11:56 AM
One of the worst stocks on the Nasdaq today is Immunomedics, Inc. (NASDAQ:IMMU), after the company said it was delaying the submission of its application for Food and Drug Administration (FDA) approv...
9/30/2019 9:11 AM
Reports suggesting the White House wanted to curb capital flows to China sparked a bearish reversal in stocks on Friday. This morning, though, futures on the Dow Jones Industrial Average (DJI) are...
7/23/2019 11:46 AM
Immunomedics, Inc. (NASDAQ:IMMU) stock topped out at an annual high of $26.99 on Sept. 4, before sliding to a 13-month low of $11.55 by mid-January. A rebound attempt was quickly rejected by the drug...
1/18/2019 10:59 AM
The shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) and Immunomedics, Inc. (NASDAQ:IMMU) are getting walloped this morning, as traders react to Food and Drug Administration (FDA) news. Specif...
1/10/2019 3:23 PM
The shares of Immunomedics, Inc. (NASDAQ:IMMU) have rebounded from their annual low of $12.86 on Dec. 20, and were last seen 2.2% higher on the day to trade at $17.62. However, traders might want to ...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center